A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
Saved in:
| Title: | A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. |
|---|---|
| Authors: | Jindani A; St George's, University of London, London, UK., Borgulya G; St George's, University of London, London, UK., de Patiño IW; Centros Broncopulmonares, Cruz Roja, Santa Cruz, Bolivia., Gonzales T; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA., de Fernandes RA; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA., Shrestha B; German Nepal Tuberculosis Project, Kathmandu, Nepal., Atwine D; Epicentre, Mbarara, Uganda., Bonnet M; Epicentre, Paris, France., Burgos M; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA., Dubash F; St George's, University of London, London, UK., Patel N; St George's, University of London, London, UK., Checkley AM; St George's, University of London, London, UK., Harrison TS; St George's, University of London, London, UK., Mitchison D; St George's, University of London, London, UK. |
| Corporate Authors: | International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis, St George's University of London |
| Source: | The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2016 Jun; Vol. 20 (6), pp. 832-8. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27155189 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jindani+A%22">Jindani A</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Borgulya+G%22">Borgulya G</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22de+Patiño+IW%22">de Patiño IW</searchLink>; Centros Broncopulmonares, Cruz Roja, Santa Cruz, Bolivia.<br /><searchLink fieldCode="AU" term="%22Gonzales+T%22">Gonzales T</searchLink>; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.<br /><searchLink fieldCode="AU" term="%22de+Fernandes+RA%22">de Fernandes RA</searchLink>; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.<br /><searchLink fieldCode="AU" term="%22Shrestha+B%22">Shrestha B</searchLink>; German Nepal Tuberculosis Project, Kathmandu, Nepal.<br /><searchLink fieldCode="AU" term="%22Atwine+D%22">Atwine D</searchLink>; Epicentre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Bonnet+M%22">Bonnet M</searchLink>; Epicentre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Burgos+M%22">Burgos M</searchLink>; Division of Infectious Diseases, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.<br /><searchLink fieldCode="AU" term="%22Dubash+F%22">Dubash F</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Checkley+AM%22">Checkley AM</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Harrison+TS%22">Harrison TS</searchLink>; St George's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mitchison+D%22">Mitchison D</searchLink>; St George's, University of London, London, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22International+Consortium+for+Trials+of+Chemotherapeutic+Agents+in+Tuberculosis%2C+St+George's+University+of+London%22">International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis, St George's University of London</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229706389%22">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</searchLink> [Int J Tuberc Lung Dis] 2016 Jun; Vol. 20 (6), pp. 832-8. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Union+against+Tuberculosis+and+Lung+Disease%22">International Union against Tuberculosis and Lung Disease </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>9706389 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1815-7920 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210273719%22">10273719 </searchLink><i>NLM ISO Abbreviation: </i>Int J Tuberc Lung Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27155189 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5588/ijtld.15.0577 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 832 Titles: – TitleFull: A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jindani A – PersonEntity: Name: NameFull: Borgulya G – PersonEntity: Name: NameFull: de Patiño IW – PersonEntity: Name: NameFull: Gonzales T – PersonEntity: Name: NameFull: de Fernandes RA – PersonEntity: Name: NameFull: Shrestha B – PersonEntity: Name: NameFull: Atwine D – PersonEntity: Name: NameFull: Bonnet M – PersonEntity: Name: NameFull: Burgos M – PersonEntity: Name: NameFull: Dubash F – PersonEntity: Name: NameFull: Patel N – PersonEntity: Name: NameFull: Checkley AM – PersonEntity: Name: NameFull: Harrison TS – PersonEntity: Name: NameFull: Mitchison D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2016 Jun Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1815-7920 Numbering: – Type: volume Value: 20 – Type: issue Value: 6 Titles: – TitleFull: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease Type: main |
| ResultId | 1 |